本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

IDEAYA Biosciences

17.45
-0.9000-4.90%
盘前17.450.00000.00%08:02 EDT
成交量:86.29万
成交额:1,514.98万
市值:15.28亿
市盈率:-4.83
高:18.63
开:18.33
低:17.42
收:18.35
数据加载中...
2024/07/11

重要事件披露

Form 8-K - Current report
2024/07/09

重要事件披露

Form 8-K - Current report
2024/07/08

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]